HUTCHMED (China) (HCM) Cash from Financing Activities (2018 - 2021)
HUTCHMED (China) (HCM) posted quarterly Cash from Financing Activities of $605.1 million for Q2 2021, up 4315.1% year-over-year from $13.7 million in Q2 2020, and up 2362.23% quarter-over-quarter from -$26.7 million in Q1 2021.
HUTCHMED (China) (HCM) Cash from Financing Activities (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has reported Cash from Financing Activities for 4 consecutive years, with $605.1 million the latest figure, recorded in Q2 2021.
- In Q2 2021, Cash from Financing Activities rose 4315.1% year-over-year to $605.1 million; the TTM figure through Jun 2021 stood at $674.7 million (up 442.5% YoY), while the FY2025 annual figure was $7.8 million, up 125.55% from the prior year.
- Cash from Financing Activities advanced to $605.1 million in Q2 2021 per HCM's latest filing, from -$26.7 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $605.1 million in Q2 2021 and bottomed at -$29.2 million in Q2 2019.
- Historically, Cash from Financing Activities has averaged $56.8 million across 4 years, with a median of -$161000.0 in 2018.
- Annual changes were most pronounced in 2019 — Cash from Financing Activities slumped 1017.16% — and 2020, when it jumped 32093.64%.
- HUTCHMED (China)'s Cash from Financing Activities stood at $16.0 million in 2018, then jumped by 67.63% to $26.9 million in 2019, then tumbled by 153.36% to -$14.4 million in 2020, then jumped by 4315.1% to $605.1 million in 2021.
- Business Quant data shows HCM's Cash from Financing Activities at $605.1 million in Q2 2021, -$26.7 million in Q1 2021, and -$14.4 million in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -1.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -813.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -1.13 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 122.40 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -1.24 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 63.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -74.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | HUTCHMED (China) | 2.19 Bn | 2.19 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 605.08 Mn |
| Jun 30, 2021 | 605.08 Mn |
| Mar 31, 2021 | -26.75 Mn |
| Mar 31, 2021 | -26.75 Mn |
| Jun 30, 2020 | -14.36 Mn |
| Jun 30, 2020 | -14.36 Mn |
| Mar 31, 2020 | 110.70 Mn |
| Mar 31, 2020 | 110.70 Mn |
| Dec 31, 2019 | 26.90 Mn |
| Dec 31, 2019 | 26.90 Mn |
| Sep 30, 2019 | 1.12 Mn |
| Sep 30, 2019 | 1.12 Mn |
| Jun 30, 2019 | -29.17 Mn |
| Jun 30, 2019 | -29.17 Mn |
| Mar 31, 2019 | -346,000.00 |
| Mar 31, 2019 | -346,000.00 |
| Dec 31, 2018 | 16.05 Mn |
| Dec 31, 2018 | 16.05 Mn |
| Sep 30, 2018 | 24,000.00 |
| Sep 30, 2018 | 24,000.00 |